Journal rankings · indicator year 2006
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2006
Biochemistry, Genetics and Molecular Biology journal rankings 2006
835 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 835 ranked journals in 2006. The median journal has an OJR of 0.87, below the world average of 1.00, up 0.03 on 2005; Q1 starts at OJR 1.42. The top three are Pharmacological Reviews, Cell, and Nature Genetics.
Ranks and citation indicators: 2006. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2003–2005, the window the 2006 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences835 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2005. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2003–2005, the window the 2006 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2003–2005 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2006. | Compare |
|---|---|---|---|---|---|---|---|
1Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 10.50Q1 | 21.20 5.51 down from 2005 | 78 | 8% | $4,500 | ||
2CellCell Press · United States | 8.00Q1 | 23.12 0.42 up from 2005 | 1,292 | 98% | $11,400 | ||
3Nature GeneticsNature Portfolio · United States | 6.61Q1 | 17.86 0.13 up from 2005 | 938 | 18% | $12,690 | ||
4NatureNature Portfolio · United Kingdom | 6.27Q1 | 10.31 0.07 down from 2005 | 8,925 | 15% | $12,690 | ||
5Annual Review of Biophysics and Biomolecular StructureAnnual Reviews · United States | 6.02Q1 | 14.64 0.43 down from 2005 | 63 | 5% | — | ||
6Progress in Lipid ResearchElsevier BV · United Kingdom | 5.75Q1 | 10.77 1.42 down from 2005 | 61 | 10% | $5,530 | ||
7Cell MetabolismCell Press · United States | 5.27Q1 | 12.06no 2005 value | 113 | 99% | $10,400 | — | |
8Systematic BiologyOxford University Press · United States | 5.22Q1 | 11.20 4.35 up from 2005 | 294 | 25% | $2,166 | ||
9FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 4.97Q1 | 7.66 1.32 down from 2005 | 165 | 53% | $3,297 | ||
10Nature BiotechnologyNature Portfolio · United States | 4.73Q1 | 8.97 0.18 up from 2005 | 1,140 | 18% | $12,690 | ||
11Briefings in BioinformaticsOAOxford University Press · United Kingdom | 4.62Q1 | 17.67 11.91 up from 2005 | 123 | 64% | $3,885 | ||
12Molecular CellElsevier BV · United States | 4.34Q1 | 13.19 0.09 down from 2005 | 1,104 | 100% | $10,400 | ||
13The American Journal of Human GeneticsElsevier BV · United States | 4.32Q1 | 11.81 0.32 up from 2005 | 959 | 91% | $5,150 | ||
14Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.32Q1 | 10.66 0.34 down from 2005 | 9,573 | 68% | — | ||
15ScienceAmerican Association for the Advancement of Science · United States | 4.26Q1 | 6.20 0.42 down from 2005 | 14,433 | 7% | — | ||
16Nature Cell BiologyNature Portfolio · United Kingdom | 4.20Q1 | 12.16 0.08 down from 2005 | 764 | 23% | $12,690 | ||
17Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 3.95Q1 | 10.80 0.94 up from 2005 | 2,620 | 94% | $5,200 | ||
18The EMBO JournalOASpringer Nature · Germany | 3.55Q1 | 10.98 0.11 up from 2005 | 1,507 | 94% | $7,990 | ||
19Pharmacology & TherapeuticsElsevier BV · United States | 3.53Q1 | 7.79 0.20 down from 2005 | 273 | 13% | $5,660 | ||
20Circulation ResearchLippincott Williams & Wilkins · United States | 3.44Q1 | 9.78 0.08 up from 2005 | 1,167 | 53% | — | ||
21Developmental CellElsevier BV · United States | 3.40Q1 | 10.31 0.50 down from 2005 | 635 | 100% | $10,400 | ||
22PLoS BiologyOAPublic Library of Science · United States | 3.22Q1 | 7.39 0.46 up from 2005 | 930 | 100% | $5,500 | ||
23Molecular & Cellular ProteomicsOAElsevier BV · United States | 3.21Q1 | 8.65 1.10 up from 2005 | 480 | 95% | $3,430 | ||
24Human Molecular GeneticsOxford University Press · United Kingdom | 3.18Q1 | 9.75 1.09 up from 2005 | 1,177 | 40% | $4,390 | ||
25TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 3.14Q1 | 3.55 0.14 down from 2005 | 413 | 8% | $5,150 | ||
26Molecular Aspects of MedicineElsevier BV · United Kingdom | 3.08Q1 | 7.05 0.40 up from 2005 | 98 | 18% | $5,220 | ||
27Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 3.03Q1 | 6.32 4.13 down from 2005 | 83 | 2% | $5,070 | ||
28Drug Metabolism ReviewsTaylor & Francis · United States | 3.01Q1 | 5.18 0.74 up from 2005 | 97 | 6% | — | ||
29Medicinal Research ReviewsWiley · United States | 3.00Q1 | 6.36 1.07 down from 2005 | 84 | 13% | $4,980 | ||
30Molecular EcologyWiley · United Kingdom | 2.97Q1 | 6.19 0.63 up from 2005 | 1,033 | 21% | $5,150 | ||
31Journal of BiologyOABioMed Central · United Kingdom | 2.97Q1 | 7.52 1.16 down from 2005 | 51 | 100% | $2,686 | ||
32Quarterly Reviews of BiophysicsCambridge University Press · United Kingdom | 2.92Q1 | 5.08 5.31 down from 2005 | 36 | 30% | $3,550 | ||
33Molecular Biology and EvolutionOAOxford University Press · United States | 2.92Q1 | 8.05 1.50 up from 2005 | 833 | 70% | $3,418 | ||
34Cancer ResearchAmerican Association for Cancer Research · United States | 2.92Q1 | 8.31 0.54 up from 2005 | 2,798 | 21% | — | ||
35Nature Structural & Molecular BiologyNature Portfolio · United States | 2.77Q1 | 8.22 0.19 up from 2005 | 682 | 21% | $12,690 | ||
36Nucleic Acids ResearchOAOxford University Press · United Kingdom | 2.72Q1 | 7.55 1.42 down from 2005 | 3,636 | 100% | $3,992 | ||
37Seminars in Cell and Developmental BiologyElsevier BV · Netherlands | 2.71Q1 | 8.91 2.77 up from 2005 | 211 | 17% | $4,670 | ||
38Nature Chemical BiologyNature Portfolio · United States | 2.69Q1 | 5.96no 2005 value | 128 | 22% | $12,690 | — | |
39Analytical ChemistryAmerican Chemical Society · United States | 2.66Q1 | 5.10 0.13 up from 2005 | 3,536 | 13% | $4,500 | ||
40Nature MethodsNature Portfolio · United States | 2.65Q1 | 6.26 2.87 up from 2005 | 388 | 18% | $12,690 | ||
41BMC Evolutionary BiologyOASpringer Science+Business Media · United Kingdom | 2.58Q1 | 5.68 0.82 up from 2005 | 150 | 100% | $2,290 | ||
42Critical Reviews in MicrobiologyTaylor & Francis · United States | 2.56Q1 | 5.46 1.60 up from 2005 | 47 | 15% | — | ||
43The Journal of PathologyPublisher not listed | 2.55Q1 | 6.13 0.64 down from 2005 | 611 | 10% | $5,450 | ||
44Molecular MicrobiologyWiley · United Kingdom | 2.54Q1 | 6.15 0.19 down from 2005 | 1,739 | 63% | $4,430 | ||
45Arteriosclerosis Thrombosis and Vascular BiologyLippincott Williams & Wilkins · United States | 2.54Q1 | 6.41 0.25 down from 2005 | 1,415 | 45% | — | ||
46Stem CellsOxford University Press · United States | 2.53Q1 | 7.62 0.72 up from 2005 | 502 | 36% | $4,477 | ||
47DevelopmentThe Company of Biologists · United Kingdom | 2.52Q1 | 8.69 0.51 up from 2005 | 1,629 | 37% | — | ||
48BioinformaticsOAOxford University Press · United Kingdom | 2.51Q1 | 6.87 0.10 down from 2005 | 1,607 | 75% | $3,989 | ||
49American Journal Of PathologyElsevier BV · United States | 2.51Q1 | 6.75 0.19 up from 2005 | 1,232 | 100% | $2,800 | ||
50Physiological ReviewsAmerican Physiological Society · United States | 2.50Q1 | 36.43 4.66 up from 2005 | 110 | 0% | — |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology707
- Genetics69
- Cancer Research20
- Cell Biology15
- Biophysics6
- Molecular Medicine6
- Biochemistry3
- Aging2
- Clinical Biochemistry2
- Structural Biology2
- Developmental Biology1
- Endocrinology1
- Physiology1
- Biotechnology0
Journals
Citations made in 2006. Corpus-wide, 71.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
222 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2003–2005, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2006. Publication window: 2003–2005. How these summaries are calculated
- Ranked journals
- 835
- Window papers (baseline)
- 441,606 +17.7% from indicator year 2003
- Median OJR
- 0.872 +14.2% from indicator year 2003
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2003–2005 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.